Posted by Michael Wonder on 13 May 2022
FDA approves novel, dual targeted treatment for type 2 diabetes
13 May 2022 - In clinical trials, treatment proved more effective than other therapies evaluated.
Today, the U.S. FDA approved Mounjaro (tirzepatide) injection to improve blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise.
